FI921596A0 - Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer. - Google Patents

Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer.

Info

Publication number
FI921596A0
FI921596A0 FI921596A FI921596A FI921596A0 FI 921596 A0 FI921596 A0 FI 921596A0 FI 921596 A FI921596 A FI 921596A FI 921596 A FI921596 A FI 921596A FI 921596 A0 FI921596 A0 FI 921596A0
Authority
FI
Finland
Prior art keywords
och
tietetronsyraderivat
fosfolifas
inhibitorer
tetron
Prior art date
Application number
FI921596A
Other languages
English (en)
Other versions
FI921596A (fi
Inventor
Craig Eugene Caufield
James Michael Rinker
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of FI921596A0 publication Critical patent/FI921596A0/fi
Publication of FI921596A publication Critical patent/FI921596A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
FI921596A 1991-04-12 1992-04-10 Tetron- och tiotetronsyraderivat och fosfolifas a2 som inhibitorer FI921596A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/685,265 US5242945A (en) 1991-04-12 1991-04-12 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors

Publications (2)

Publication Number Publication Date
FI921596A0 true FI921596A0 (fi) 1992-04-10
FI921596A FI921596A (fi) 1992-10-13

Family

ID=24751448

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921596A FI921596A (fi) 1991-04-12 1992-04-10 Tetron- och tiotetronsyraderivat och fosfolifas a2 som inhibitorer

Country Status (14)

Country Link
US (1) US5242945A (fi)
EP (1) EP0508690A1 (fi)
JP (1) JPH0597839A (fi)
KR (1) KR920019770A (fi)
AU (1) AU649120B2 (fi)
CA (1) CA2065228A1 (fi)
FI (1) FI921596A (fi)
HU (1) HUT61738A (fi)
IE (1) IE920880A1 (fi)
IL (1) IL101444A (fi)
MX (1) MX9201657A (fi)
NZ (1) NZ242301A (fi)
TW (1) TW206219B (fi)
ZA (1) ZA922181B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9302419A (es) * 1992-04-28 1994-03-31 American Home Prod Derivados de acido tetronico, tiotetronico y tetramico.
US5428058A (en) * 1994-09-28 1995-06-27 American Home Products Corporation Phospholipase A2 inhibitors
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
AU721881B2 (en) * 1996-03-27 2000-07-13 Toray Industries, Inc. Ketone derivatives and medicinal use thereof
WO1997035565A1 (fr) * 1996-03-27 1997-10-02 Toray Industries, Inc. Derives de cetone et usage medicinal
GB2321455A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Lipophilic derivatives of biologically active compounds
DE69927466T3 (de) * 1998-12-22 2010-02-11 Unilever N.V. Kosmetische Verwendung von Petroselinsäure
US6900242B2 (en) * 2001-06-13 2005-05-31 Magnachem International Laboratories, Inc. Lactone formulations and method of use
MXPA05004794A (es) * 2002-11-05 2005-08-19 Magnachem Int Lab Inc Formulaciones de lactonas y metodos de uso.
WO2005102315A1 (en) 2004-04-23 2005-11-03 Magnachem International Laboratories, Inc. Synthetic lactone formulations for pain control
CA2741526A1 (en) * 2008-10-24 2010-04-29 Magnachem International Laboratories, Inc. Method for screening for compounds selectively interacting with rad9
CN117802156A (zh) * 2024-02-29 2024-04-02 云南师范大学 硼酸转运蛋白基因在转基因植株筛选中的应用及筛选方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1276061A (en) * 1970-01-14 1972-06-01 Ici Ltd Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds
JPS4969659A (fi) * 1972-10-31 1974-07-05
JPS511633A (ja) * 1974-06-25 1976-01-08 Toray Industries Noengeiyosatsukinzai
US4874782A (en) * 1985-07-01 1989-10-17 Eli Lilly And Company Furanone derivatives
JPS6219582A (ja) * 1985-07-19 1987-01-28 Agency Of Ind Science & Technol γ−チオブチロラクトン誘導体の製造方法
US5045564A (en) * 1988-12-07 1991-09-03 Allergan, Inc. Anti-inflammatory 2-furanones

Also Published As

Publication number Publication date
NZ242301A (en) 1997-03-24
CA2065228A1 (en) 1992-10-13
FI921596A (fi) 1992-10-13
MX9201657A (es) 1992-10-01
EP0508690A1 (en) 1992-10-14
US5242945A (en) 1993-09-07
IE920880A1 (en) 1992-10-21
KR920019770A (ko) 1992-11-19
HU9201238D0 (en) 1992-07-28
IL101444A0 (en) 1992-12-30
AU1482692A (en) 1992-10-15
IL101444A (en) 1997-02-18
ZA922181B (en) 1993-09-27
HUT61738A (en) 1993-03-01
AU649120B2 (en) 1994-05-12
JPH0597839A (ja) 1993-04-20
TW206219B (fi) 1993-05-21

Similar Documents

Publication Publication Date Title
FI921952A0 (fi) Foerfarande foer framstaellning av dialkylenpiperidinofoereningar och enantiomerer daerav anvaendbara som laekemedel.
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
FI914004A (fi) Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen.
FI923558A0 (fi) Tetrahydroindazol-, tetrahydrocyklo -pentapyrazol- och hexahydrocykloheptapyrazolfoereningar och deras anvaendning som inhibitorer av hmg-coa-reduktas.
FI915357A0 (fi) Optisk bakskiva som foerbinder kretskort.
FI914797A0 (fi) Maettade hydroxialkylkinolinsyror som leukotrienantagonister.
FI923185A0 (fi) Foerfarande och anordning foer framstaellning av fogloesa band- och traodoeglor och deras anvaendning som kapverktyg i band- och traodsaogar.
FI923756A0 (fi) Polyolefinkompositioner som omfattar glycerolmonoestrar av c20-24-fettsyror och daerav framstaellda skumprodukter.
FI912468A0 (fi) Oxidantkaensliga och -okaensliga aromatiska estrar som inhibitorer foer humant neutrofilelastas.
FI921974A0 (fi) Lageranlaeggning och undervattens- drivkraftsenhet som innehaoller den.
FI915568A0 (fi) Polyamidhartskompositioner foer anvaendning som bindemedel foer laminerande tryckfaergshartser.
FI921596A0 (fi) Tetron- och tietetronsyraderivat och fosfolifas a2 som inhibitorer.
FI913138A0 (fi) Foerfarande foer framstaellning av b -laktamer som innehaoller aminotiazol(iminooxiaettiksyra) aettiksyrasidokedjor och mellanprodukter daerav.
FI915609A (fi) Foerfarande och anordning foer styrning av en m-pulsvaexelriktaranordning som bestaor av en mastervaexelriktare och aotminstone en slavvaexelriktare.
FI922472A0 (fi) Gingerol- och gingerdiolderivat som hypokolesterolemiska och antiaterosklerostiska medel.
FI922225A0 (fi) Aminosyraazetidinylsubstituerade pyridonderivat samt deras framstaellning och anvaendning som laekemedel.
FI922783A0 (fi) Polymerfoereningar innehaollande steriskt hindrade aminogrupper och anvaendbara som stabilisatorer samt polymerkompositioner innehaollande desamma.
FI922782A0 (fi) Polymerfoereningar innehaollande steriskt hindrade aminogrupper och anvaendbara som stabilisatorer samt polymerkompositioner innehaollande desamma.
FI910197A0 (fi) Foerfarande och anordning foer skogsgallring.
FI913241A0 (fi) Foerfarande foer anvaendning av fjaeder baode som fjaeder och begraensare och anordning foer tillaempning av foerfarandet.
FI910271A (fi) Braennanordning som omfattar en cirkulerande flytbaedd.
FI914323A0 (fi) Vattentaett glastegelelement som taol mekanisk anstraengning och kemisk anstraengning.
FI905530A (fi) Foerfarande foer foergasning av fast braensle och foergasare som anvaends i foerfarandet.
FI914989A0 (fi) Kraftverk som anvaender stroemmande vatten.
FI910937A0 (fi) Engaongsdaempare foer anordning som hindrar medfallande.